Table 2. Acute rejection rate in different CYP3A5 genotype.
Characteristics | FK506 | CsA | ||
---|---|---|---|---|
GG | AA/AG | GG | AA/AG | |
Patient, n (AA/AG) | 65 | 58 (11/47) | 52 | 43 (9/34) |
Acute rejection, n(%) | 4(6.15%)a | 8(13.79%) | 10(19.23%) | 6(13.95%) |
Acute rejection based on type of Immunosuppressive drugs, n(%) | 12(9.76%) | 16(16.84%) | ||
Total acute rejection, n(%) | 28(12.84%) |
a : p < 0.05 vs CYP3A5*GG with CsA treatment.